Literature DB >> 10561525

Neuro-Behcet's disease in Iraq: a study of 40 patients.

S A Al-Fahad1, A H Al-Araji.   

Abstract

Behcet's disease (BD) is a chronic, multisystemic disorder with variable prevalence in different geographical areas. Neurological manifestations (neuro-Behcet's disease, NBD) are well recognized. We studied 40 Iraqi patients with NBD from a neurological unit in a large teaching hospital, all fulfilling the International Study group criteria for the diagnosis of BD. There were 37 males and three females. Thirty-nine were Arab Muslims and one was a Kurd Muslim. Mean age at neurological presentation was 29+/-7.6 years (range 18-50 years). Fifteen out of 23 tested patients (65%) had a positive pathergy test and seven out of 13 tested (54%) had HLA-B5(51). A classification into three reasonably clear distinctive main patterns of neurological presentation is proposed. First: a parenchymal CNS pattern (the commonest) - 26 patients (65%), which included three relatively common forms: brain stem syndrome (10 patients), diffuse form (predominantly with pseudobulbar signs) (nine patients) and cerebral stroke-like form (five patients); and two less common forms: psychiatric and myelopathy (one patient each). Second: intracranial hypertension (IH) (with papilledema) - 11 patients (27.5%). Third: meningitis-like pattern - three patients (7. 5%). This classification has clinical, etiopathological, therapeutic and prognostic implications. In conclusion, NBD is not uncommon in Iraq, and it affects predominately Arab Muslims. BD should be routinely looked for in adult patient, especially males, in their third and fourth decades who present with IH and papilledema, brain stem syndrome, pseudobulbar palsy, stroke, meningitis or myelopathy.

Entities:  

Mesh:

Year:  1999        PMID: 10561525     DOI: 10.1016/s0022-510x(99)00165-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.

Authors:  A Al-Araji; K Sharquie; Z Al-Rawi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Neurological disorders in Iraqi refugees in Jordan: data from the United Nations Refugee Assistance Information System.

Authors:  Farrah J Mateen; Marco Carone; Sayre Nyce; Jad Ghosn; Timothy Mutuerandu; Huda Al-Saedy; Daniel H Lowenstein; Gilbert Burnham
Journal:  J Neurol       Date:  2011-09-28       Impact factor: 4.849

3.  Response to comment on "Cerebral venous thrombosis in Behcet's disease: a systematic review" by Afshin Borhani-Haghighi and Anahid Safari.

Authors:  Diana Aguiar de Sousa; Tiago Mestre; José Ferro
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

Review 4.  Neurological complications of Behçet's syndrome.

Authors:  Desmond Kidd
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 5.  Cerebral venous thrombosis in Behçet's disease: a systematic review.

Authors:  D Aguiar de Sousa; T Mestre; J M Ferro
Journal:  J Neurol       Date:  2011-01-06       Impact factor: 4.849

6.  Cranial hypertension as first manifestation of Behçet's disease: a case report.

Authors:  F J Ascaso; A Rodriguez; J A Cristóbal
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

7.  Neuro-Behçet's disease: a report of sixteen patients.

Authors:  Radi Shahien; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

8.  Aseptic meningitis as the sole manifestation of Behçet's disease.

Authors:  Ryuji Sakakibara; Nobukiyo Koide; Masahiko Kishi; Emina Ogawa; Kohji Shirai
Journal:  Neurol Sci       Date:  2009-07-02       Impact factor: 3.307

Review 9.  Optic neuropathy in Behçet's syndrome.

Authors:  Desmond P Kidd
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

10.  Epilepsy associated with systemic autoimmune disorders.

Authors:  Orrin Devinsky; Adam Schein; Souhel Najjar
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.